BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1050 related articles for article (PubMed ID: 18408734)

  • 1. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
    Tatham MH; Geoffroy MC; Shen L; Plechanovova A; Hattersley N; Jaffray EG; Palvimo JJ; Hay RT
    Nat Cell Biol; 2008 May; 10(5):538-46. PubMed ID: 18408734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.
    Lallemand-Breitenbach V; Jeanne M; Benhenda S; Nasr R; Lei M; Peres L; Zhou J; Zhu J; Raught B; de Thé H
    Nat Cell Biol; 2008 May; 10(5):547-55. PubMed ID: 18408733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic-induced SUMO-dependent recruitment of RNF4 into PML nuclear bodies.
    Geoffroy MC; Jaffray EG; Walker KJ; Hay RT
    Mol Biol Cell; 2010 Dec; 21(23):4227-39. PubMed ID: 20943951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.
    Percherancier Y; Germain-Desprez D; Galisson F; Mascle XH; Dianoux L; Estephan P; Chelbi-Alix MK; Aubry M
    J Biol Chem; 2009 Jun; 284(24):16595-16608. PubMed ID: 19380586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
    Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
    PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E1B-55K-Mediated Regulation of RNF4 SUMO-Targeted Ubiquitin Ligase Promotes Human Adenovirus Gene Expression.
    Müncheberg S; Hay RT; Ip WH; Meyer T; Weiß C; Brenke J; Masser S; Hadian K; Dobner T; Schreiner S
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29695423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation.
    Erker Y; Neyret-Kahn H; Seeler JS; Dejean A; Atfi A; Levy L
    Mol Cell Biol; 2013 Jun; 33(11):2163-77. PubMed ID: 23530056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML.
    Fasci D; Anania VG; Lill JR; Salvesen GS
    Sci Signal; 2015 Jun; 8(380):ra56. PubMed ID: 26060329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.
    Zhang XW; Yan XJ; Zhou ZR; Yang FF; Wu ZY; Sun HB; Liang WX; Song AX; Lallemand-Breitenbach V; Jeanne M; Zhang QY; Yang HY; Huang QH; Zhou GB; Tong JH; Zhang Y; Wu JH; Hu HY; de Thé H; Chen SJ; Chen Z
    Science; 2010 Apr; 328(5975):240-3. PubMed ID: 20378816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promyelocytic leukemia protein stimulates SUMO conjugation in yeast.
    Quimby BB; Yong-Gonzalez V; Anan T; Strunnikov AV; Dasso M
    Oncogene; 2006 May; 25(21):2999-3005. PubMed ID: 16501610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PML isoforms in response to arsenic: high-resolution analysis of PML body structure and degradation.
    Hands KJ; Cuchet-Lourenco D; Everett RD; Hay RT
    J Cell Sci; 2014 Jan; 127(Pt 2):365-75. PubMed ID: 24190887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML.
    Weisshaar SR; Keusekotten K; Krause A; Horst C; Springer HM; Göttsche K; Dohmen RJ; Praefcke GJ
    FEBS Lett; 2008 Sep; 582(21-22):3174-8. PubMed ID: 18708055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.
    Rabellino A; Carter B; Konstantinidou G; Wu SY; Rimessi A; Byers LA; Heymach JV; Girard L; Chiang CM; Teruya-Feldstein J; Scaglioni PP
    Cancer Res; 2012 May; 72(9):2275-84. PubMed ID: 22406621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequences related to SUMO interaction motifs in herpes simplex virus 1 protein ICP0 act cooperatively to stimulate virus infection.
    Everett RD; Boutell C; Pheasant K; Cuchet-Lourenço D; Orr A
    J Virol; 2014 Mar; 88(5):2763-74. PubMed ID: 24352468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An arginine-rich motif of ring finger protein 4 (RNF4) oversees the recruitment and degradation of the phosphorylated and SUMOylated Krüppel-associated box domain-associated protein 1 (KAP1)/TRIM28 protein during genotoxic stress.
    Kuo CY; Li X; Kong XQ; Luo C; Chang CC; Chung Y; Shih HM; Li KK; Ann DK
    J Biol Chem; 2014 Jul; 289(30):20757-72. PubMed ID: 24907272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.
    Cao X; Clavijo C; Li X; Lin HH; Chen Y; Shih HM; Ann DK
    Mol Cancer Ther; 2008 Apr; 7(4):923-34. PubMed ID: 18413806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumoylation of the Tumor Suppressor Promyelocytic Leukemia Protein Regulates Arsenic Trioxide-Induced Collagen Synthesis in Osteoblasts.
    Xu WX; Liu SZ; Wu D; Qiao GF; Yan J
    Cell Physiol Biochem; 2015; 37(4):1581-91. PubMed ID: 26517826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0.
    Boutell C; Orr A; Everett RD
    J Virol; 2003 Aug; 77(16):8686-94. PubMed ID: 12885887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation.
    Izumiya Y; Kobayashi K; Kim KY; Pochampalli M; Izumiya C; Shevchenko B; Wang DH; Huerta SB; Martinez A; Campbell M; Kung HJ
    PLoS Pathog; 2013; 9(8):e1003506. PubMed ID: 23990779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO-1 promotes association of SNURF (RNF4) with PML nuclear bodies.
    Häkli M; Karvonen U; Jänne OA; Palvimo JJ
    Exp Cell Res; 2005 Mar; 304(1):224-33. PubMed ID: 15707587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.